The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) |
93.242 |
PAR-22-082 |
| Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
93.350, 93.865 |
PAR-22-100 |
| NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed) |
93.866 |
PAR-22-110 |
| FY22 Commercial Motor Vehicle Operator Safety Training Program (CMVOST) |
20.235 |
FM-DTG-22-001 |
| Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
93.350, 93.865 |
PAR-22-101 |
| Transforming Pediatrics for Early Childhood (TPEC) |
93.110 |
HRSA-22-141 |
| Native American Elder Justice Initiative |
93.047 |
HHS-2022-ACL-AOA-IERC-0070 |
| Sb-oedwb-22-001 (msi) |
59.043 |
SB-OEDWB-22-001 |
| SB-OEDWB-22-002 |
59.043 |
SB-OEDWB-22-002 |
| Louisiana Conservation Delivery Technical Assistance |
10.902 |
USDA-NRCS-LA-MULTI-22-NOFO0001151 |
| USAID/Kosovo Inclusive Economic Engagement Activity |
98.001 |
72016722RFA00004 |
| Integrative Research in Gynecologic Health (R01 Clinical Trial Optional) |
93.313, 93.865 |
RFA-HD-23-006 |
| Leadership for the Employment and Economic Advancement of People with Disabilities Workforce Innovation and Opportunity Act Policy Development Center |
17.720 |
FOA-ODEP-22-10 |
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) |
93.242 |
PAR-22-112 |
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) |
93.242 |
PAR-22-113 |
| 2022 Ambassador's Special Self-Help Program |
19.220 |
NGA-POLECON-GR-22-002-012822 |
| Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional) |
93.313, 93.361, 93.865 |
RFA-NR-22-003 |
| Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) |
93.307, 93.313, 93.361, 93.865 |
RFA-NR-22-002 |
| Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
93.113, 93.121, 93.173, 93.213, 93.233, 93.279, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.866, 93.879 |
PAR-22-078 |
| Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) |
93.242, 93.279, 93.307, 93.361 |
RFA-NR-22-001 |
| BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-22-115 |
| Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-012 |
| Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-013 |
| Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-014 |
| NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) |
93.242 |
RFA-MH-22-155 |
| Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-010 |
| Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-23-011 |
| ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) |
93.837, 93.838, 93.839, 93.859 |
RFA-HL-23-001 |
| ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed) |
93.837, 93.838, 93.839, 93.859 |
RFA-HL-23-002 |
| Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-22-005 |
| Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials |
93.213, 93.242, 93.273, 93.279, 93.846, 93.865, 93.866 |
RFA-MH-22-175 |
| Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
93.213, 93.242, 93.273, 93.279, 93.846, 93.865, 93.866 |
RFA-MH-22-176 |
| HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) |
93.121, 93.213, 93.350, 93.393, 93.846, 93.865, 93.866 |
RFA-DE-22-011 |
| Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional) |
93.113 |
RFA-ES-22-002 |
| Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) |
93.121, 93.213, 93.273, 93.279, 93.313, 93.350, 93.398, 93.846, 93.853, 93.866 |
PAR-22-058 |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-22-099 |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-22-145 |
| Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) |
93.213, 93.273, 93.350, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866 |
RFA-TR-22-013 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) |
93.393 |
PAR-22-083 |
| Cybersecurity for Small Business Pilot Program |
59.079 |
SB-OEDCS-22-001 |
Search Results 2641-2680 of 21019
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next] |
